Company Profile
Dynavax Technologies Stock Price, News & Analysis
- Ticker:
- DVAX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for DVAX.
Company overview
Business overview
Dynavax Technologies is a vaccine company best known for HEPLISAV-B and additional innate-immune platform work. The company combines commercial product execution with immunology-driven pipeline optionality.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Dynavax sits in specialty biopharma.
Business Model Characteristics
The business depends on vaccine sales, commercial traction, and the ability to expand beyond its core hepatitis-B franchise.
Position Within the Biotechnology Landscape
Dynavax is a commercial specialty-pharma name with catalyst sensitivity around vaccines, partnerships, and pipeline progress.
Future catalysts
Dynavax's catalysts are HEPLISAV-B execution and CpG 1018 adjuvant partnerships, which together support the vaccine-platform story. The company improves when the commercial base and partner flow both stay healthy.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Dynavax Technologies do?
Dynavax Technologies is a vaccine company best known for HEPLISAV-B and additional innate-immune platform work. The company combines commercial product execution with immunology-driven pipeline optionality.
On which exchange is DVAX stock listed?
Dynavax Technologies (DVAX) is associated with NASDAQ, United States, Biopharma.
What is HEPLISAV-B?
Dynavax's catalysts are HEPLISAV-B execution and CpG 1018 adjuvant partnerships, which together support the vaccine-platform story.
Which conditions is Dynavax Technologies targeting with HEPLISAV-B?
Dynavax Technologies is associated with immunology based on its company overview and current catalyst commentary.
How does Dynavax Technologies describe recent progress with HEPLISAV-B?
Dynavax's catalysts are HEPLISAV-B execution and CpG 1018 adjuvant partnerships, which together support the vaccine-platform story.
What is Dynavax?
Dynavax Technologies is a vaccine company best known for HEPLISAV-B and additional innate-immune platform work.
What should investors watch for with Dynavax?
Dynavax's catalysts are HEPLISAV-B execution and CpG 1018 adjuvant partnerships, which together support the vaccine-platform story.
What is Technologies?
Dynavax Technologies is a vaccine company best known for HEPLISAV-B and additional innate-immune platform work.